CIRCULOGENE
Kathy Tabatabaee is a Molecular Oncology Specialist and Western Regional Business Director at Circulogene since September 2015. Prior to that, Kathy worked as a Cancer Diagnostic Specialist at Innovative Diagnostic Laboratory from May 2014 to September 2015 and as a Cardio Diagnostic Specialist at Atherotech from 2010 to 2014. Kathy is an alumnus of UCLA.
This person is not in any offices
CIRCULOGENE
Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence.